Evidence map›Paper›PMID 38766668›Full record

ArticlePsychiatry and clinical psychopharmacology2022

Factors Associated with Problematic Cannabis Use in a Sample of Medical Cannabis Dispensary Users.

Lindsay A Lo, Caroline A MacCallum, Jade C Yau, William J Panenka, Alasdair M Barr

Abstract readCase Reports
In one paragraph

Article in Psychiatry and clinical psychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lindsay A LoFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.ORCID 0000-0001-8501-3238
Caroline A MacCallumDepartment of Psychology, Queen's University, Kingston, Canada.ORCID 0000-0002-3407-1574
Jade C YauDepartment of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Faculty of Medicine, Vancouver, Canada.ORCID 0000-0002-7889-3959
William J PanenkaDepartment of Psychology, Queen's University, Kingston, Canada.ORCID 0000-0003-3101-9487
Alasdair M BarrUniversity of British Columbia, Faculty of Medicine, Vancouver, Canada.ORCID 0000-0001-7143-6512

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With the recent legalization of cannabis for medical purposes in many countries, there has been an increased number of individuals using such products. While there is considerable evidence indicating that cannabis may have therapeutic effects for a range of different conditions, concerns remain about the risk of developing cannabis use disorders for those at risk, or patients without appropriate clinical guidance. The aim of the present study was to determine the prevalence of problematic cannabis use in a cohort of cannabis users who consumed the drug for medical purposes and to identify potential risk factors. Methods: One hundred individuals who self-identified as using cannabis to improve their mental health were recruited from a community dispensary. Extensive details were collected about subjects' patterns of cannabis use and reasons for use. All subjects completed a structured clinical interview with the Mini-International Neuropsychiatric Interview, while information about perceived stress, depressive symptoms, and somatic symptoms were recorded with the Perceived Stress Scale-10, Beck Depression Inventory, and the Patient Health Questionnaire-15. Results: Rates of problematic cannabis use were high, with 30% meeting the criteria. Only 10% of subjects reported medical cannabis use was recommended by their doctor. Significant risk factors for problematic use included earlier age of cannabis initiation, as well as self-reported use of cannabis products for depression. Conclusions: The prevalence of problematic cannabis use in the community dispensary was higher than expected. Specific risk factors for problematic cannabis use may represent important areas for future intervention to ensure safer consumption for medical purposes.

Indexed as

Addictionbehavioral addictioncannabispsychiatrypsychopharmacology

Identifiers

PMID38766668
PMCPMC11099647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.